Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vallance

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1995
A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjectsF Mailly, Y Tugrul, P W Reymer, et al.
Journal of Inherited Metabolic Disease|December 25, 2004
Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathyN Makhseed, H D Vallance, M Potter, et al.
Molecular Genetics and Metabolism|June 13, 2006
A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathyScot C Leary, Andre Mattman, Timothy Wai, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|February 1, 1993
Effects of simvastatin on apoB metabolism and LDL subfraction distributionA Gaw, C J Packard, E F Murray, et al.
Mitochondrion|August 17, 2018
A mitochondrial DNA D loop insertion detected almost exclusively in non-replicating tissues with maternal inheritance across three generationsMehul A Sharma, Ja Young J Lee, Andrea Tam, et al.
Plos One|July 7, 2022
Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohortNadjoua Maouche, Bhuvan Kishore, Zara Bhatti, et al.
Molecular Genetics and Metabolism|February 17, 2009
The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populationsCheryl R Greenberg, Louise A Dilling, G Robert Thompson, et al.
Leukemia & Lymphoma|December 28, 2020
Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experienceNadjoua Maouche, Bhuvan Kishore, Matthew W Jenner, et al.
Clinical Biochemistry|March 14, 2003
A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiencyNelson L S Tang, Joannie Hui, Collin K K Yong, et al.
Annals of Hematology|April 3, 2020
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myelomaEvangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1995
A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjectsF Mailly, Y Tugrul, P W Reymer, et al.
Journal of Inherited Metabolic Disease|December 25, 2004
Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathyN Makhseed, H D Vallance, M Potter, et al.
Molecular Genetics and Metabolism|June 13, 2006
A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathyScot C Leary, Andre Mattman, Timothy Wai, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|February 1, 1993
Effects of simvastatin on apoB metabolism and LDL subfraction distributionA Gaw, C J Packard, E F Murray, et al.
Mitochondrion|August 17, 2018
A mitochondrial DNA D loop insertion detected almost exclusively in non-replicating tissues with maternal inheritance across three generationsMehul A Sharma, Ja Young J Lee, Andrea Tam, et al.
Plos One|July 7, 2022
Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohortNadjoua Maouche, Bhuvan Kishore, Zara Bhatti, et al.
Molecular Genetics and Metabolism|February 17, 2009
The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populationsCheryl R Greenberg, Louise A Dilling, G Robert Thompson, et al.
Leukemia & Lymphoma|December 28, 2020
Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experienceNadjoua Maouche, Bhuvan Kishore, Matthew W Jenner, et al.
Clinical Biochemistry|March 14, 2003
A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiencyNelson L S Tang, Joannie Hui, Collin K K Yong, et al.
Annals of Hematology|April 3, 2020
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myelomaEvangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, et al.
Pageof 7